Blume Capital Management’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-600
Closed -$24.7K 339
2022
Q4
$24.7K Hold
600
0.01% 200
2022
Q3
$26K Sell
600
-200
-25% -$9.69K 0.01% 189
2022
Q2
$39K Hold
800
0.02% 174
2022
Q1
$45K Sell
800
-200
-20% -$10.6K 0.01% 165
2021
Q4
$52K Hold
1,000
0.02% 174
2021
Q3
$60K Buy
+1,000
New +$61.7K 0.02% 161

Other funds holding NUVA

Blume Capital Management's NUVA Position: Q1 2023 in Review

Blume Capital Management sold out of NuVasive, Inc. (NUVA) in Q1 2023, closing a stake of 600 shares — an estimated $24.7K sold.

Blume Capital Management first reported a position in NUVA in Q3 2021 and held it in 6 quarters. The position peaked at $60K in Q3 2021. 241 funds tracked by Wall St. Rank hold NUVA as of Q1 2023.

  • Blume Capital Management reported no remaining NuVasive, Inc. position as of Q1 2023 after selling out during the quarter.
  • Blume Capital Management sold 600 NuVasive, Inc. shares in Q1 2023, an estimated $24.7K.
  • Blume Capital Management first reported a position in NuVasive, Inc. in Q3 2021 and held it in 6 quarters.
  • Blume Capital Management's NuVasive, Inc. position peaked at $60K in Q3 2021.
  • 241 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2023.

Based on Blume Capital Management's 13F filing for Q1 2023, filed 8 May 2023.